Cancer Care at the Crossroads Ny, March 25, 2016
Total Page:16
File Type:pdf, Size:1020Kb
2016 CANCER CARE AT THE CROSSROADS NY, MARCH 25, 2016 A One-Day International Summit on Innovation, Clinical Benefit and Cost Meet the Sponsors Program 7:45am – 8:00am Opening remarks Setting the stage for the day Opening remarks MIKE MEYER ROBERT DARNELL President, Meyer Consulting MD, PhD, Founding Director and CEO, New York Genome Center; Professor & Senior Physician, The Rockefeller University; Investigator, Howard Hughes Medical Institute 8:00am – 9:15am Round table 1 Cancer care delivery and cost through the lens of health plans, academic centers, pharma and provider groups and how they perveive each other Round table 1 Round Moderator Speaker Speaker Speaker Speaker CHERYL A. MOORE HAL PAZ MACE ROTHENBERG JEFFREY LEBENGER RICHARD SCHILSKY President and COO, MD, Executive Vice President MD, Chief Medical Officer and Senior Vice MD, Chairman & CEO, Summit Medical Group MD, Chief Medical Officer, American New York Genome Center and Chief Medical Officer, Aetna President, Clinical Development & Summit Health Management Society of Clinical Oncology and Medical Affairs, Pfizer Oncology 2 Copyright© 2016 Meyer Consulting meyerconsultinginc.com 3 Meet the Sponsors Program 7:45am – 8:00am Opening remarks Setting the stage for the day Opening remarks MIKE MEYER ROBERT DARNELL President, Meyer Consulting MD, PhD, Founding Director and CEO, New York Genome Center; Professor & Senior Physician, The Rockefeller University; Investigator, Howard Hughes Medical Institute 8:00am – 9:15am Round table 1 Cancer care delivery and cost through the lens of health plans, academic centers, pharma and provider groups and how they perveive each other Round table 1 Round Moderator Speaker Speaker Speaker Speaker CHERYL A. MOORE HAL PAZ MACE ROTHENBERG JEFFREY LEBENGER RICHARD SCHILSKY President and COO, MD, Executive Vice President MD, Chief Medical Officer and Senior Vice MD, Chairman & CEO, Summit Medical Group MD, Chief Medical Officer, American New York Genome Center and Chief Medical Officer, Aetna President, Clinical Development & Summit Health Management Society of Clinical Oncology and Medical Affairs, Pfizer Oncology 2 Copyright© 2016 Meyer Consulting meyerconsultinginc.com 3 Program 9:15am – 10:30am Round table 2 12:00pm – 1:00pm Lunch served at conference center How to innovate and leverage the resources and talent of academic medical centers in collaboration with community physicans 1:00pm – 2:00pm Round table 4 Strategies/ tools for assessing and improving the quality of care and reducing costs Round table 2 Round Round table 4 Round Speaker Speaker Speaker Speaker ALEXANDER EGGERMONT ANDREW NORDEN MARGARET B. ROW JEFFREY LEBENGER Moderator Speaker Speaker Speaker MD, PhD, Director General, Gustave Roussy; MD, MPH, Associate Chief Medical Officer, MD, VP of Networks MD MD, Chairman & CEO, Summit Medical Group Chairman, Cancer Core Europe Network, Dana-Farber Cancer Institute Anderson Cancer Center & Summit Health Management GLENN D. POMERANTZ MAUREEN SULLIVAN ELISABETH DE VRIES ANDREW PECORA MD, JD, Vice President and Chief Medical Officer, Senior Vice President, Strategic Services and MD, PhD, Professor and Head, Department Chief Innovations Officer; Professor and Vice President Horizon Blue Cross Blue Shield of New Jersey Chief Strategy Officer, Blue Cross and Blue Shield of Medical Oncology, University of Cancer Services, John Theurer Cancer Center 10:30am – 10:45am Morning break Association (BCBSA) Medical Center Groningen at Hackensack University Medical Center 10:45am – 12:00pm Round table 3 2:00pm – 3:00pm Round table 5 The use of genomics, precision medicine and targeted therapies Public perceptions of cancer treatment, prevention and survivorship to improve quality and reduce cost of care Round table 3 Round Round table 5 Round Speaker Speaker Speaker Speaker Moderator Speaker Speaker Speaker STEPHEN G. EMERSON MACE ROTHENBERG ROBERT DARNELL RAZELLE KURZROCK DAVID NANUS ROBERT BAZELL FRANCES M. VISCO LARS HJORTH MD, PhD, Director, Herbert Irving Comprehensive Cancer MD, Chief Medical Officer and Senior Vice President, MD, PhD, Founding Director and CEO, New York Genome MD, PHD, Senior Deputy Center Director, Clinical MD, Chief, Hematology/Medical Oncology, PhD, Professor, Yale University; Former Chief Health JD, President, National Breast Cancer Coalition MD, PhD, Consultant Pediatric Hematology/ Center; Clyde and Helen Wu Professor in Immunology, Clinical Development and Medical Affairs, Center; Professor & Senior Physician, The Rockefeller Science; Director, Clinical Trials Office; Director, Centerfor NewYork-Presbyterian/Weill Cornell; Associate Director, and Science Correspondent for NBC Oncology, Skane University Hospital, Lund University; Columbia University College of Physicians and Surgeons; Pfizer Oncology University; Investigator, Howard Hughes Medical Institute Personalized Cancer Therapy; Chief, Division of Hematology Meyer Cancer Center, Weill Cornell Medicine Chairman, PanCare Associate Dean for Oncology at CUMC; and Director and Oncology Leader, Experimental Therapeutics Program; of Oncology Services for New York-Presbyterian Hospital. Murray Professor of Medicine, UC San Diego Health 4 Copyright© 2016 Meyer Consulting meyerconsultinginc.com 4 meyerconsultinginc.com 5 Program 9:15am – 10:30am Round table 2 12:00pm – 1:00pm Lunch served at conference center How to innovate and leverage the resources and talent of academic medical centers in collaboration with community physicans 1:00pm – 2:00pm Round table 4 Strategies/ tools for assessing and improving the quality of care and reducing costs Round table 2 Round Round table 4 Round Speaker Speaker Speaker Speaker ALEXANDER EGGERMONT ANDREW NORDEN MARGARET B. ROW JEFFREY LEBENGER Moderator Speaker Speaker Speaker MD, PhD, Director General, Gustave Roussy; MD, MPH, Associate Chief Medical Officer, MD, VP of Networks MD MD, Chairman & CEO, Summit Medical Group Chairman, Cancer Core Europe Network, Dana-Farber Cancer Institute Anderson Cancer Center & Summit Health Management GLENN D. POMERANTZ MAUREEN SULLIVAN ELISABETH DE VRIES ANDREW PECORA MD, JD, Vice President and Chief Medical Officer, Senior Vice President, Strategic Services and MD, PhD, Professor and Head, Department Chief Innovations Officer; Professor and Vice President Horizon Blue Cross Blue Shield of New Jersey Chief Strategy Officer, Blue Cross and Blue Shield of Medical Oncology, University of Cancer Services, John Theurer Cancer Center 10:30am – 10:45am Morning break Association (BCBSA) Medical Center Groningen at Hackensack University Medical Center 10:45am – 12:00pm Round table 3 2:00pm – 3:00pm Round table 5 The use of genomics, precision medicine and targeted therapies Public perceptions of cancer treatment, prevention and survivorship to improve quality and reduce cost of care Round table 3 Round Round table 5 Round Speaker Speaker Speaker Speaker Moderator Speaker Speaker Speaker STEPHEN G. EMERSON MACE ROTHENBERG ROBERT DARNELL RAZELLE KURZROCK DAVID NANUS ROBERT BAZELL FRANCES M. VISCO LARS HJORTH MD, PhD, Director, Herbert Irving Comprehensive Cancer MD, Chief Medical Officer and Senior Vice President, MD, PhD, Founding Director and CEO, New York Genome MD, PHD, Senior Deputy Center Director, Clinical MD, Chief, Hematology/Medical Oncology, PhD, Professor, Yale University; Former Chief Health JD, President, National Breast Cancer Coalition MD, PhD, Consultant Pediatric Hematology/ Center; Clyde and Helen Wu Professor in Immunology, Clinical Development and Medical Affairs, Center; Professor & Senior Physician, The Rockefeller Science; Director, Clinical Trials Office; Director, Centerfor NewYork-Presbyterian/Weill Cornell; Associate Director, and Science Correspondent for NBC Oncology, Skane University Hospital, Lund University; Columbia University College of Physicians and Surgeons; Pfizer Oncology University; Investigator, Howard Hughes Medical Institute Personalized Cancer Therapy; Chief, Division of Hematology Meyer Cancer Center, Weill Cornell Medicine Chairman, PanCare Associate Dean for Oncology at CUMC; and Director and Oncology Leader, Experimental Therapeutics Program; of Oncology Services for New York-Presbyterian Hospital. Murray Professor of Medicine, UC San Diego Health 4 Copyright© 2016 Meyer Consulting meyerconsultinginc.com 4 meyerconsultinginc.com 5 Program Speakers 3:00pm – 3:15pm Afternoon break 3:15pm – 4:30pm Round table 6 The challenges facing health plans and governments in financing new innovative treatments - alternative payment models INDRANIL BAGCHI ROBERT BAZELL ROBERT B. DARNELL PhD, Vice President and Head, Payer Insights Professor, Yale University; Former Chief Health MD, PhD Founding Director and CEO, and Access, Global Health and Value, Pfizer and Science Correspondent for NBC New York Genome Center Dr. Indranil Bagchi is Vice President and Head of Payer Insights Robert Bazell is adjunct professor in the Department Dr. Darnell’s career in neurology and genomics spans Round table 6 Round and Access at Pfizer, where he leads efforts to understand of Molecular Cellular and Developmental Biology. Before over 25 years and includes his role as the Heilbrunn payer perspectives and develop the market access strategy his arrival at Yale in 2013 he served for 38 years as chief Professor at The Rockefeller University and a Howard Moderator Speaker Speaker Speaker Speaker for the entire Pfizer portfolio, including the payer value science and health correspondent for NBC News. In that Hughes Medical Institute Investigator. Dr. Darnell is a Senior proposition,